Shavit Capital
Private equity
Active
Jerusalem, Israel
13
56M
10
0.76
5
0.23
4
- Areas of investment
Summary
In 2007 was created Shavit Capital, which is appeared as VC. The fund was located in Asia if to be more exact in Israel. The main department of described VC is located in the Jerusalem.
The overall number of key employees were 2.
The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Israel. Among the most popular portfolio startups of the fund, we may highlight Syqe Medical, PolyPid, Gamida Cell. Among the most popular fund investment industries, there are Medical, Therapeutics.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2018. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 80 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Shavit Capital performs on 21 percentage points more the average number of lead investments.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Shavit Capital, startups are often financed by Teva Pharmaceutical Industries, Philip Morris International, Israel Innovation Authority. The meaningful sponsors for the fund in investment in the same round are Clal Biotechnology Industries, VT Ventures, Novartis. In the next rounds fund is usually obtained by Israel Innovation Authority.
Investor highlights
- Industry generalist
- Yes
- Industry focus
- Stage focus
- Geo focus
- Check size
- Up to 15M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 13
- Lead investments
- 5
- Exits
- 4
- Rounds per year
- 0.76
- Follow on index
- 0.23
- Investments by industry
- Health Care (9)
- Biotechnology (7)
- Medical Device (4)
- Medical (4)
- Pharmaceutical (3) Show 20 more
- Investments by region
-
- Israel (11)
- United States (2)
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 179M
- Group Appearance index
- 0.85
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Veev | 23 Mar 2021 | Real Estate, Building Material, Construction, Smart Building, Smart Home, Property Development | Late Stage Venture | 100M | United States, California |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.